Summit Therapeutics Inc.
SMMT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $105 | $71 | $349 | $72 |
| Short-Term Investments | $307 | $115 | $0 | $0 |
| Receivables | $1 | $1 | $6 | $24 |
| Inventory | $0 | $0 | $0 | $7 |
| Other Curr. Assets | $11 | $3 | $302 | $8 |
| Total Curr. Assets | $424 | $190 | $657 | $97 |
| Property Plant & Equip (Net) | $7 | $6 | $5 | $3 |
| Goodwill | $2 | $2 | $2 | $2 |
| Intangibles | $0 | $0 | $0 | $10 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $3 | $5 | $1 | $0 |
| Total NC Assets | $12 | $13 | $7 | $16 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $436 | $203 | $664 | $113 |
| Liabilities | – | – | – | – |
| Payables | $5 | $3 | $0 | $4 |
| Short-Term Debt | $4 | $3 | $21 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $8 |
| Other Curr. Liab. | $33 | $15 | $17 | $13 |
| Total Curr. Liab. | $42 | $20 | $39 | $26 |
| LT Debt | $3 | $103 | $497 | $1 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $2 | $2 | $1 | $3 |
| Total NC Liab. | $5 | $105 | $499 | $4 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $7 | $6 | $4 | $2 |
| Total Liabilities | $47 | $125 | $538 | $30 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $7 | $7 | $2 | $1 |
| Retained Earnings | -$1,215 | -$993 | -$378 | -$300 |
| AOCI | -$2 | -$2 | -$2 | -$2 |
| Other Equity | $1,598 | $1,066 | $505 | $384 |
| Total Equity | $389 | $78 | $127 | $83 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $436 | $203 | $664 | $113 |
| Net Debt | -$98 | $35 | $170 | -$69 |